TABLE 3.
Estimated prevalence of elevated soluble transferrin receptor unadjusted and after the exclusion of individuals with inflammation in preschool children and women of reproductive age: the BRINDA project1
| Survey | n | Unadjusted, % | Subjects with AGP concentrations >1 g/L, n (%) | AGP concentration ≤1 g/L,2 % |
| Preschool children | ||||
| Bangladesh | 1493 | 55.7 (52.0, 59.4)3 | 994 (33.4) | 53.5 (49.7, 57.4) |
| Cameroon | 774 | 68.2 (63.7, 72.7) | 483 (39.3) | 62.3 (57.0, 67.6) |
| Côte d’Ivoire | 733 | 24.2 (20.2, 28.2) | 250 (64.5) | 10.0 (5.8, 14.3) |
| Kenya 2007 | 888 | 35.5 (31.1, 39.9) | 318 (64.2) | 26.1 (20.8, 31.4) |
| Kenya 2010 | 843 | 74.7 (71.0, 78.5) | 331 (60.7) | 62.8 (56.9, 68.8) |
| Laos | 481 | 4.1 (1.9, 6.2) | 287 (41.7) | 3.7 (1.2, 6.2) |
| Liberia | 1434 | 76.7 (73.5, 80.0) | 672 (56.2) | 70.2 (65.5, 75.0) |
| Philippines | 1767 | 13.5 (10.2, 16.8) | 1345 (54.4) | 11.9 (8.8, 14.9) |
| Papua New Guinea | 868 | 25.1 (20.7, 29.5) | 392 (21.2) | 14.3 (10.1, 18.6) |
| Women of reproductive age | ||||
| Cameroon | 751 | 34.0 (29.2, 38.8) | 698 (7.2) | 32.1 (27.3, 36.9) |
| Côte d’Ivoire | 816 | 31.1 (27.0, 35.3) | 599 (26.9) | 28.7 (24.0, 33.3) |
| Laos | 816 | 5.8 (3.5, 8.0) | 734 (9.3) | 4.9 (2.8, 7.0) |
| Liberia | 1875 | 28.6 (25.4, 31.7) | 1677 (10.4) | 27.0 (23.9, 30.1) |
| Papua New Guinea | 746 | 17.7 (14.2, 21.3) | 584 (21.9) | 15.2 (11.9, 18.4) |
1
AGP, α-1-acid-glycoprotein; BRINDA, Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia.
2
Elevated soluble transferrin receptor concentrations (>8.3 mg/L) in the subset of the sample with nonelevated inflammation.
3
95% CIs in parentheses (all such values).